Call for Abstracts - VPH Research to Business Session

8-9 September 2010, Barcelona, Spain.
The vision of the Virtual Physiological Human is a grand challenge. A key feature of the VPH initiative is the promise of some low-hanging fruits, applications where the power of multiscale simulation technology can be placed into clinical and industrial practices in the not-so-distant future. Viewed in this light, it is essential for all VPH projects to actively disseminate their research results towards the biomedical industry.

For the second year, the VPH Network of Excellence is organising a two-day meeting where the VPH community showcases its best results to the biomedical industry. This is not only to increase the exploitation potential of VPH research, but also to expand the take-on of VPH technologies in the health industry.

This year the program revolves around three types of sessions:

  • Research to Business (R2B), where research consortia present to industry delegates the best results they achieved;
  • Business to Business (B2B), where small and large companies, as well as university spin-offs present products and services that other companies can use to develop other products and services for the final end-user.
  • Regulatory to Business (G2B), where experts of regulatory affair will report on the position of simulation technologies with respect to regulatory affairs.

VPH research projects are invited to participate in this event in three ways:

  • Ensuring that industrial partners of your consortia are informed of the event and are motivated to send delegates
  • Explore with their industrial partners or spin-offs the interest to present their products and services at the B2B session. Those interested should contact Elena Villalba Mora, This email address is being protected from spambots. You need JavaScript enabled to view it..
  • Submit an abstract of the presentation on the best research results they would like to showcase in the R2B session.

Selection Criteria
The draft programme consists of 12 slots of 30-minutes for each presentation. In the event that abstracts received are more than the number of available slots, the organisation of the event will make a selection according to the following criteria:

  • Fair representation of all projects (if two abstracts come from the same project one might be excluded)
  • Broadest possible coverage of the clinical and industrial domains
  • Closeness of results to be presented to the industrial/clinical exploitation

Consortia and research groups who wish to present, should follow the instructions below.

Submission of Abstracts
Your abstract must reach the event organisers no later than the 23rd of April 2010. Selected contributions will be invited for presentation during the 8th and 9th of September 2010.

Instructions for Submission of Abstracts
Please send your abstract to Vanessa Diaz, This email address is being protected from spambots. You need JavaScript enabled to view it. Abstracts will be between 350 and 500 words long, without including the title and the authors. The format is free; feel free to include illustrations.

Abstract Contents
Abstracts should cover the following topics:

  • Subject of research
  • Clinical and/or industrial translation
  • Clinical uptake
  • Development of tools if any

Evaluation
The event organisers will evaluate all abstracts. Notification of acceptance will be provided the last week of April.

For further information, please visit:
http://www.vph-noe.eu

About the VPH Network of Excellence
The VPH Network of Excellence (VPH NoE) is designed to foster, harmonise and integrate pan-European research in the field of i) patient-specific computer models for personalised and predictive healthcare and ii) ICT-based tools for modelling and simulation of human physiology and disease-related processes.

The main objectives of the VPH Network of Excellence are to support the:

  • Coordination of research portfolios of VPH NoE partners through initiation of Exemplar integrative research projects that encourage inter-institution and interdisciplinary VPH research.
  • Integration of research infrastructures of VPH NoE partners through development of the VPH ToolKit: a shared and mutually accessible source of research equipment, managerial and research infrastructures, facilities and services.
  • Development of a portfolio of interdisciplinary training activities including a formal consultation on, and assessment of, VPH careers.
  • Establishment of a core set of VPH-related dissemination and networking activities which will engage everyone from partners within the VPH NoE/other VPH projects, to national policy makers, to the public at large.
  • Creation of Industrial, Clinical and Scientific Advisory Boards that will jointly guide the direction of the VPH NoE and, through consultation, explore the practical and legal options for real and durable integration within the VPH research community.
  • Implementation of key working groups that will pursue specific issues relating to VPH, notably integrating VPH research worldwide through international physiome initiatives.

Finally, by involving clinical and industrial stakeholders, VPH NoE also plans to lay a reliable ground to support sustainable interactions and collaboration between research and healthcare communities.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...